Dietary Fiber for Colorectal Cancer
Trial Summary
What is the purpose of this trial?
This clinical trial tests whether daily fiber supplementation will change the mucosal microbiome of the colon. The microbiome are microorganisms that live in the human gut. They serve a vital role in maintaining health. Certain microbial strains are associated with the growth of colon polyps, which eventually could go on to form colon cancer. Giving dietary fiber supplements may help prevent precancerous polyps from ever developing.
Research Team
Vassiliki L Tsikitis, M.D.
Principal Investigator
OHSU Knight Cancer Institute
Eligibility Criteria
This trial is for adults over 18 who've had a colonoscopy in the last 2 years and have benign anorectal issues like hemorrhoids, without cancer or Crohn's disease. They must understand and sign consent. It's not for those with hereditary colon cancer syndromes, past colon surgery, active malignancy, inflammatory bowel diseases or immunosuppression.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive dietary fiber orally once daily for 28 days
Follow-up
Participants are monitored for changes in microbiome diversity and abundance after fiber supplementation
Treatment Details
Interventions
- Dietary Fiber
- Proctoscopy or Anoscopy with Biopsy
Find a Clinic Near You
Who Is Running the Clinical Trial?
OHSU Knight Cancer Institute
Lead Sponsor